Canonical event

Google and Yale announce C2S-Scale 27B and an in-vitro-validated cancer immunology hypothesis

On 15 October 2025 Google announced Cell2Sentence-Scale 27B built on Gemma, available to researchers, and reported in-vitro human cell-model validation of the predicted combination of silmitasertib and low-dose interferon increasing antigen presentation. The experiment was reported in cells, not in human clinical trials; no cancer treatment efficacy or regulatory approval is established. The cited preprint originated earlier, and the October event is the public announcement and model release.